Mammalian wound healing is a complex, multi-step process that must be tightly regulated. Whereas synthesis of extracellular matrix is an essential step in wound healing, excessive matrix deposition can lead to the formation of fibrotic scars, resulting in compromised structure and function of the affected organ or tissue. Some of the deleterious consequences of fibrotic wound healing include liver cirrhosis, pulmonary fibrosis, and congestive heart failure. On the other hand, deficient matrix deposition can play a role in impaired wound healing leading to chronic non-healing wounds, a complication for which patients with diabetes are at particular risk. Our recent studies have revealed that in the course of normal cutaneous wound healing, myofibroblasts in the granulation tissue are driven into senescence by CCN1, a matricellular protein that is dynamically expressed at sites of wound repair. CCN1 induces cellular senescence through a novel integrin-mediated pathway, and activates the expression of an anti-fibrotic genetic program characteristic of senescent cells. Mutant knockin mice that express a senescence-defective CCN1 do not accumulate senescent cells and suffer exacerbated fibrosis in wounds. These results support the hypothesis that CCN1-dependent cellular senescence is a programmed wound healing response that controls fibrogenesis. However, this mechanism of fibrosis control may become deregulated under pathological conditions, leading to excessive senescent cell accumulation and contributing to the chronicity of non-healing wounds. We will investigate the role of CCN1-induced cellular senescence in cutaneous wound healing in three specific aims:
Aim 1 dissects the molecular mechanism of CCN1-induced senescence;
Aim 2 evaluates the role of cellular senescence in controlling fibrosis during wound healing;
and Aim 3 elucidates the effects of senescent cells on chronic non-healing wounds. Together, these studies will advance our knowledge of how cellular senescence participates in fibrosis control and chronicity in wound healing.
Wound healing is a complex, multi-step process that must be tightly regulated. Excessive deposition of extracellular matrix often occurs in association with chronic injuries, and may result in fibrosis with serious consequences such as liver cirrhosis and pulmonary fibrosis. Impaired wound healing can also lead to chronic non-healing wounds, which may require amputations. This proposal seeks to understand the role of cellular senescence in wound healing, which may underlie the pathologies of both fibrotic wound healing and chronic non-healing wounds. We anticipate that our results will prompt new therapeutic strategies that may reduce the morbidity and mortality associated with impaired wound healing.
|Jun, Joon-Ii; Lau, Lester F (2017) CCN2 induces cellular senescence in fibroblasts. J Cell Commun Signal 11:15-23|
|Monzon, Ricardo I; Kim, Ki-Hyun; Lau, Lester F (2017) Construction and Analysis of an Allelic Series of Ccn1 Knockin Mice. Methods Mol Biol 1489:361-376|
|Lau, Lester F (2016) Cell surface receptors for CCN proteins. J Cell Commun Signal 10:121-7|
|Chen, C-C; Kim, K-H; Lau, L F (2016) The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene 35:1314-23|
|Jun, Joon-Il; Kim, Ki-Hyun; Lau, Lester F (2015) The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing. Nat Commun 6:7386|
|Choi, J S; Kim, K-H; Lau, L F (2015) The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol 8:1285-96|
|Zemans, Rachel L; McClendon, Jazalle; Aschner, Yael et al. (2013) Role of ?-catenin-regulated CCN matricellular proteins in epithelial repair after inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 304:L415-27|
|Kim, Ki-Hyun; Chen, Chih-Chiun; Monzon, Ricardo I et al. (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33:2078-90|
|Choi, Jinok; Lin, Ann; Shrier, Eric et al. (2013) Degradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina. J Biol Chem 288:23075-89|
|Lau, Lester F (2012) CCN1 and CCN2: blood brothers in angiogenic action. J Cell Commun Signal 6:121-3|
Showing the most recent 10 out of 14 publications